2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Therapeutic Advances in Gastroenterology THER ADV GASTROENTER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 6.9
51人评分
我要评分
声誉 8.3 影响力 5.8 速度 6.9 | |||||||||||||||||||||
| 期刊ISSN | 1756-2848 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| P-ISSN | 1756-283X | |||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 3.9 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：2.487 | |||||||||||||||||||||
| 2023-2024自引率 | 2.60%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 4 | |||||||||||||||||||||
| JCI期刊引文指标 | 0.68 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://journals.sagepub.com/home/tag | |||||||||||||||||||||
| 期刊投稿网址 | http://www.sagepub.com/journals/Journal201897#submission-guidelines | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Therapeutic Advances in Gastroenterology的语言要求，还能让Therapeutic Advances in Gastroenterology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Therapeutic Advances in Gastroenterology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD2700; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：gastroenterology、gastrointestinal disorders、hepatic disorders、hepatology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP | |||||||||||||||||||||
| 出版商 | SAGE Publications Ltd | |||||||||||||||||||||
| 涉及的研究方向 | Medicine-Gastroenterology | |||||||||||||||||||||
| 出版国家或地区 | United Kingdom | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 143点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 93.20% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 57.34% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-2848%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 15 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD2700; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Therapeutic Advances in Gastroenterology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn's disease receiving ustekinumab Author: Zhou, Longyuan; Hu, Cicong; Zhang, Ruonan; Qiu, Yun; Wang, Yu; Liu, Zishan; Chen, Baili; He, Yao; Zeng, Zhirong; Li, Xuehua; Mao, Ren; Chen, Minhu Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231170947 PubMed DOI |
| 2. | Gastrointestinal injury induced by immunomodulators: A review article Author: Zhang, Pingxin; Mao, Ren; Zhang, Chuhan; Qiu, Yun; Chen, Minhu Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231158549 PubMed DOI |
| 3. | An explainable artificial intelligence system for diagnosing Helicobacter Pylori infection under endoscopy: a case-control study Author: Zhang, Mengjiao; Pan, Jie; Lin, Jiejun; Xu, Ming; Zhang, Lihui; Shang, Renduo; Yao, Liwen; Li, Yanxia; Zhou, Wei; Deng, Yunchao; Dong, Zehua; Zhu, Yijie; Tao, Xiao; Wu, Lianlian; Yu, Honggang Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231155023 PubMed DOI |
| 4. | Characteristics of fecal microbiota in different constipation subtypes and association with colon physiology, lifestyle factors, and psychological status Author: Yu, Ting; Ding, Yu; Qian, Dong; Lin, Lin; Tang, Yurong Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231154101 PubMed DOI |
| 5. | Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis Author: Xu, Wentao; Bai, Zhaohui; Shang, Yiyang; Wang, Jing; Wong, Yujun; Qi, Xingshun Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231167858 PubMed DOI |
| 6. | Randomized clinical trial: the effects of pregabalin for centrally mediated abdominal pain syndrome Author: Xu, Ri; Wang, Yanyan; Han, Wei Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231152334 PubMed DOI |
| 7. | Early predictive value of scoring systems and routine laboratory tests in severity and prognosis of acute pancreatitis in pregnancy Author: Wang, Yu; Qu, Guangbo; Wu, Zhangbi; Tian, Dongmei; Yang, Wenbei; Li, Hongye; Lu, Yu; Meng, GuangJun; Zhang, Hong Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231167277 PubMed DOI |
| 8. | Effect of antidepressants on psychological comorbidities, disease activity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis Author: Wang, Liangfang; Liang, Chang; Chen, Pingrun; Cao, Yubin; Zhang, Yan Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231155022 PubMed DOI |
| 9. | Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study Author: Wang, Kang; Liu, Zong-Han; Yu, Hong-Ming; Cheng, Yu-Qiang; Xiang, Yan-Jun; Zhong, Jing-Ya; Ni, Qian-Zhi; Zhou, Li-Ping; Liang, Chao; Zhou, Hong-Kun; Pan, Wei-Wei; Guo, Wei-Xing; Shi, Jie; Cheng, Shu-Qun Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231160630 PubMed DOI |
| 10. | Prognostic analysis and nomogram establishment in patients with early esophageal cancer receiving endoscopic therapy: a population-based study Author: Sun, Danping; Yi, Jun; Gong, Lingqi; Wu, Yu; Liu, Xiaowei Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023; Vol. 16, Issue , pp. -. DOI: 10.1177/17562848231170470 PubMed DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
